These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2677410)

  • 1. Terodiline: a dose titrated, multicenter study of the treatment of idiopathic detrusor instability in women.
    Tapp A; Fall M; Norgaard J; Massey A; Choa R; Carr T; Korhonen M; Abrams P
    J Urol; 1989 Oct; 142(4):1027-31. PubMed ID: 2677410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of terodiline on patients with detrusor instability.
    Macfarlane JR; Tolley DA
    Scand J Urol Nephrol Suppl; 1984; 87():51-4. PubMed ID: 6399954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terodiline. A review of its pharmacological properties, and therapeutic use in the treatment of urinary incontinence.
    Langtry HD; McTavish D
    Drugs; 1990 Nov; 40(5):748-61. PubMed ID: 2292235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terodiline, emepronium bromide or placebo for treatment of female detrusor overactivity? A randomised, double-blind, cross-over study.
    Andersen JR; Lose G; Nørgaard M; Stimpel H; Andersen JT
    Br J Urol; 1988 Apr; 61(4):310-3. PubMed ID: 3289675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terodiline in the treatment of women with urgency and motor urge incontinence. A clinical and urodynamic double-blind cross-over study.
    Gerstenberg TC; Klarskov P; Ramirez D; Hald T
    Br J Urol; 1986 Apr; 58(2):129-33. PubMed ID: 3516296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terodiline in the treatment of urinary frequency and motor urge incontinence. A controlled multicentre trial.
    Peters D
    Scand J Urol Nephrol Suppl; 1984; 87():21-33. PubMed ID: 6399953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder training and terodiline in females with idiopathic urge incontinence and stable detrusor function.
    Klarskov P; Gerstenberg TC; Hald T
    Scand J Urol Nephrol; 1986; 20(1):41-6. PubMed ID: 3704568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial.
    Petersen T; Jakobsen J
    J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1331-6. PubMed ID: 3681312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terodiline with bladder retraining for treating detrusor instability in elderly people.
    Wiseman PA; Malone-Lee J; Rai GS
    BMJ; 1991 Apr; 302(6783):994-6. PubMed ID: 2039897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of terodiline on urinary incontinence among older non-institutionalized women. Terodiline in the Elderly American Multicenter Study Group.
    J Am Geriatr Soc; 1993 Sep; 41(9):915-22. PubMed ID: 8409177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terodiline treatment of detrusor hyperreflexia in sclerosis multiplex.
    Jensen D
    J Oslo City Hosp; 1989; 39(6-7):67-73. PubMed ID: 2674379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of terodiline hydrochloride in patients with urinary frequency or incontinence].
    Yasuno H; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Kataoka N; Matsushita M; Inaba Y; Umezu K; Yamashita M
    Hinyokika Kiyo; 1991 Apr; 37(4):431-9. PubMed ID: 1892003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of long-term safety and clinical benefit of terodiline in women with urgency/urge incontinence. A multicentre study.
    Fischer-Rasmussen W
    Scand J Urol Nephrol Suppl; 1984; 87():35-47. PubMed ID: 6443541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect of terodiline hydrochloride on nervous pollakisuria or irritative bladder].
    Yoneyama T; Ogawa A; Fukui J; Wajiki M; Tomita Y; Igawa Y; Yanagisawa A; Uchiyama S; Watanabe K; Aida Y
    Hinyokika Kiyo; 1987 Feb; 33(2):319-26. PubMed ID: 3591595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic effects of intravesical instillation of terodiline in healthy volunteers and in patients with detrusor hyperactivity.
    Ekström B; Andersson KE; Mattiasson A
    J Urol; 1992 Dec; 148(6):1840-3; discussion 1843-4. PubMed ID: 1433617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A symptomatic and cystometric comparison of terodiline with emepronium in the treatment of women with frequency, urgency and incontinence.
    Sole GM; Arkell DG
    Scand J Urol Nephrol Suppl; 1984; 87():55-7. PubMed ID: 6399955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind trial of terodiline in the treatment of urge incontinence in women.
    Norton P; Karram M; Wall LL; Rosenzweig B; Benson JT; Fantl JA
    Obstet Gynecol; 1994 Sep; 84(3):386-91. PubMed ID: 8058236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effects of terodiline hydrochloride on urinary frequency and sense of residual urine--a double blind clinical trial using flavoxate hydrochloride as a control].
    Ogawa A; Shimazaki J; Mitsuya H; Miyazaki S; Kurita T
    Hinyokika Kiyo; 1988 Apr; 34(4):739-53. PubMed ID: 3041785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence.
    Thomas SH; Higham PD; Hartigan-Go K; Kamali F; Wood P; Campbell RW; Ford GA
    Br Heart J; 1995 Jul; 74(1):53-6. PubMed ID: 7662454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of terodiline hydrochloride for the treatment of urinary frequency and urinary incontinence, and its cardiovascular adverse effects].
    Yoshihara H; Yasumoto R; Kishimoto T; Maekawa M; Horii A; Nishijima T; Sugimoto T; Kashiwara N; Tsujita M; Senjyu M
    Hinyokika Kiyo; 1992 Aug; 38(8):967-72. PubMed ID: 1414748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.